Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Depreciation & Amortization
$127.60M
TTM · Period ending: · USD

BIO Depreciation & Amortization
Latest reported$127.60Mperiod ending
Latest reported$127.60Mperiod ending
BIO TTM Depreciation & Amortization ($10.30M → $127.60M)
TTM Depreciation & Amortization
High-resolution chart · PNG
BIO depreciation & amortization history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 41,829,000 | |
| 42,923,000 | |
| 43,309,000 | |
| 43,330,000 | |
| 38,426,000 | |
| 32,988,000 | |
| 27,500,000 | |
| 22,300,000 | |
| 21,600,000 | |
| 21,100,000 | |
| 21,000,000 | |
| 21,700,000 | |
| 20,700,000 | |
| 20,400,000 | |
| 19,500,000 | |
| 18,800,000 | |
| 19,000,000 | |
| 18,100,000 | |
| 17,900,000 | |
| 16,600,000 | |
| 16,300,000 | |
| 16,500,000 | |
| 16,700,000 | |
| 16,700,000 | |
| 16,800,000 | |
| 16,700,000 | |
| 16,800,000 | |
| 16,700,000 | |
| 17,000,000 | |
| 17,400,000 | |
| 16,600,000 | |
| 16,100,000 | |
| 15,500,000 | |
| 14,200,000 | |
| 13,900,000 | |
| 13,900,000 | |
| 13,100,000 | |
| 12,700,000 | |
| 12,100,000 | |
| 11,100,000 | |
| 10,700,000 | |
| 10,600,000 | |
| 10,300,000 | |
| 9,600,000 | |
| 9,100,000 |